Adding 11,000 sq.-ft. of production space segregated and designed to handle cytotoxic and highly active products for prescription softgel manufacturing.
Catalent will provide vial filling, packaging capacity and additional staffing for 24x7 manufacturing ops to support production of an initial 100 million doses.